Recombinant human chorionic gonadotropin (r-hCG)
Sponsors
EMD Serono, Merck KGaA, Darmstadt, Germany, University of California, San Diego, Regionshospitalet Viborg, Skive
Conditions
Assisted Reproductive TechniquesControlled Ovarian StimulationFertilityFollicle Stimulating Hormone DeficiencyHypogonadotropic HypogonadismInfertilityOvulation InductionPCOS
Phase 2
Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)
CompletedNCT00505752
Start: 2007-01-31End: 2008-09-30Updated: 2014-02-13
AS900672-Enriched in Ovulation Induction
TerminatedNCT00553514
Start: 2007-12-31End: 2009-03-31Updated: 2014-02-13
Phase 3
Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
CompletedNCT01154192
Start: 2011-08-31End: 2014-09-30Updated: 2019-04-30
PERgoveriS In Stratified Treatment for Assisted Reproductive Technique
CompletedNCT01297465
Start: 2011-05-31End: 2012-10-31Updated: 2021-05-28
A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique
TerminatedNCT01497197
Start: 2012-05-31End: 2014-01-31Updated: 2015-11-09
Phase 4
Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])
TerminatedNCT00328926
Start: 2006-03-31End: 2012-05-31Updated: 2013-08-07
Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)
CompletedNCT01339299
Start: 2009-10-31End: 2012-07-31Updated: 2013-11-27